1928 Circulation October 22, 2013 mental health, functional status, activity limitations,
cancerrelated pain, and cancer-related anxiety) declined moderately to severely in 44%. 5 …

Cardiac toxicity is one of the most concerning side effects of anti-cancer therapy. The gain in
life expectancy obtained with anti-cancer therapy can be compromised by increased …

In the United States alone, there are currently approximately 14.5 million cancer survivors,
and this number is expected to increase to 20 million by 2020. Cancer therapies can cause …

Background The magnitude of cardiovascular morbidity in paediatric, adolescent, and young
adult survivors of Hodgkin's lymphoma is not known. Using medically ascertained data, we …

Newer biologic drugs and immunomodulatory agents, as well as more tolerated and
effective radiation therapy schemes, have reduced treatment toxicity in oncology patients …

Radiation exposure to the thorax is associated with substantial risk for the subsequent
development of cardiovascular disease. Thus, the increasing role of radiation therapy in the …

Since the 1990s, there has been a steady increase in the number of cancer survivors to an
estimated 17 million in 2019 in the US alone. Radiation therapy today is applied to a variety …

Long-term survivors of Hodgkin lymphoma (HL) experience several late adverse effects of
treatment, with second malignant neoplasms (SMNs) and cardiovascular diseases (CVDs) …

Background Coronary artery disease (CAD) is a concerning late outcome for cancer
survivors. However, uniform surveillance guidelines are lacking. Aim To harmonise …

Cardio-Oncology is a rapidly growing sub-specialty of medicine, however, there is very
limited guidance on the use of cardiac CT (CCT) in the care of Cardio-Oncology patients. In …